| Product Code: ETC8666818 | Publication Date: Sep 2024 | Updated Date: Apr 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Norway`s import shipments of drug-device combination products in 2024 were primarily sourced from the UK, Germany, USA, Denmark, and Metropolitan France. The market showed a low level of concentration with a Herfindahl-Hirschman Index (HHI) remaining low. The compound annual growth rate (CAGR) from 2020 to 2024 was steady at 3.86%, indicating sustained growth in this sector. Furthermore, the impressive growth rate of 27.79% from 2023 to 2024 suggests a swift expansion in the import market for drug-device combination products in Norway.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Norway Drug-Device Combination Products Market Overview |
3.1 Norway Country Macro Economic Indicators |
3.2 Norway Drug-Device Combination Products Market Revenues & Volume, 2022 & 2032F |
3.3 Norway Drug-Device Combination Products Market - Industry Life Cycle |
3.4 Norway Drug-Device Combination Products Market - Porter's Five Forces |
3.5 Norway Drug-Device Combination Products Market Revenues & Volume Share, By Product, 2022 & 2032F |
3.6 Norway Drug-Device Combination Products Market Revenues & Volume Share, By Application, 2022 & 2032F |
3.7 Norway Drug-Device Combination Products Market Revenues & Volume Share, By End user, 2022 & 2032F |
4 Norway Drug-Device Combination Products Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases in Norway leading to higher demand for drug-device combination products |
4.2.2 Technological advancements in drug delivery systems and medical devices |
4.2.3 Favorable government regulations promoting the development and adoption of drug-device combination products |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for approval of drug-device combination products |
4.3.2 High development costs and lengthy approval processes |
4.3.3 Limited awareness and education among healthcare professionals and patients about the benefits of drug-device combination products |
5 Norway Drug-Device Combination Products Market Trends |
6 Norway Drug-Device Combination Products Market, By Types |
6.1 Norway Drug-Device Combination Products Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Norway Drug-Device Combination Products Market Revenues & Volume, By Product, 2022 - 2032F |
6.1.3 Norway Drug-Device Combination Products Market Revenues & Volume, By Drug-eluting stents, 2022 - 2032F |
6.1.4 Norway Drug-Device Combination Products Market Revenues & Volume, By Infusion pumps, 2022 - 2032F |
6.1.5 Norway Drug-Device Combination Products Market Revenues & Volume, By Photodynamic therapy, 2022 - 2032F |
6.1.6 Norway Drug-Device Combination Products Market Revenues & Volume, By Antimicrobial wound dressings, 2022 - 2032F |
6.1.7 Norway Drug-Device Combination Products Market Revenues & Volume, By Prefilled syringes, 2022 - 2032F |
6.1.8 Norway Drug-Device Combination Products Market Revenues & Volume, By Drug-eluting balloons, 2022 - 2032F |
6.1.9 Norway Drug-Device Combination Products Market Revenues & Volume, By Other, 2022 - 2032F |
6.1.10 Norway Drug-Device Combination Products Market Revenues & Volume, By Other, 2022 - 2032F |
6.2 Norway Drug-Device Combination Products Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Norway Drug-Device Combination Products Market Revenues & Volume, By Cardiovascular Disorders, 2022 - 2032F |
6.2.3 Norway Drug-Device Combination Products Market Revenues & Volume, By Diabetes, 2022 - 2032F |
6.2.4 Norway Drug-Device Combination Products Market Revenues & Volume, By Respiratory Problems, 2022 - 2032F |
6.2.5 Norway Drug-Device Combination Products Market Revenues & Volume, By Cancer Treatment, 2022 - 2032F |
6.2.6 Norway Drug-Device Combination Products Market Revenues & Volume, By Antimicrobial Application, 2022 - 2032F |
6.2.7 Norway Drug-Device Combination Products Market Revenues & Volume, By Other, 2022 - 2032F |
6.3 Norway Drug-Device Combination Products Market, By End user |
6.3.1 Overview and Analysis |
6.3.2 Norway Drug-Device Combination Products Market Revenues & Volume, By Hospital & clinic, 2022 - 2032F |
6.3.3 Norway Drug-Device Combination Products Market Revenues & Volume, By Ambulatory surgery center (asc), 2022 - 2032F |
6.3.4 Norway Drug-Device Combination Products Market Revenues & Volume, By Home care setting, 2022 - 2032F |
6.3.5 Norway Drug-Device Combination Products Market Revenues & Volume, By Other, 2022 - 2032F |
7 Norway Drug-Device Combination Products Market Import-Export Trade Statistics |
7.1 Norway Drug-Device Combination Products Market Export to Major Countries |
7.2 Norway Drug-Device Combination Products Market Imports from Major Countries |
8 Norway Drug-Device Combination Products Market Key Performance Indicators |
8.1 Adoption rate of drug-device combination products in healthcare facilities |
8.2 Number of partnerships and collaborations between pharmaceutical companies and medical device manufacturers |
8.3 Investment in research and development of innovative drug-device combination products |
9 Norway Drug-Device Combination Products Market - Opportunity Assessment |
9.1 Norway Drug-Device Combination Products Market Opportunity Assessment, By Product, 2022 & 2032F |
9.2 Norway Drug-Device Combination Products Market Opportunity Assessment, By Application, 2022 & 2032F |
9.3 Norway Drug-Device Combination Products Market Opportunity Assessment, By End user, 2022 & 2032F |
10 Norway Drug-Device Combination Products Market - Competitive Landscape |
10.1 Norway Drug-Device Combination Products Market Revenue Share, By Companies, 2025 |
10.2 Norway Drug-Device Combination Products Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here